Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 6Recruiting 5Unknown 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Nasopharyngeal Carcinoma 8Esophageal Squamous Cell Carcinoma 7Carcinoma, Non-Small-Cell Lung 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Triple Negative Breast Neoplasms 4Recurrence 3Pancreatic Neoplasms 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Neoplasm Metastasis 2Muscle Invasive Bladder Cancer (MIBC) 2Biliary Tract Neoplasms 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Sarcoma 1Salivary Gland Malignant Neoplasms 1SCLC, Extensive Stage 1Rectal Neoplasms 1Rare Tumour 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-Muscle Invasive Bladder Neoplasms 1Non Squamous Non Small Cell Lung Cancer 1Neoplasms 1NSCLC 1Muscle-invasive Bladder Urothelial Carcinoma 1Melanoma 1Esophageal Neoplasms 1

Interventions

toripalimab 2trastuzumab deruxtecan 1tislelizumab 1envafolimab 1enfortumab vedotin 1conteltinib 1Pemetrexed 1Oxaliplatin 1Injections 1Gemcitabine 1Cisplatin 1Carboplatin 1Capecitabine 1CD3 Complex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Advanced Solid Tumor × toripalimab × Clear all
NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

Nanjing Immunophage Biotech Co., Ltd

Phase 1/2 Not yet recruiting
52 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06873854 2025-03-13

A Study of LM-108 in Combination With Toripalimab in Subjects With Advanced Solid Tumours

LaNova Medicines Limited

Phase 2 Not yet recruiting
84 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡